secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001140361-24-044715
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics raises ~$3M in registered direct offering of 9.9M shares and warrants at $0.3039/unit
--------------------------------------------------------------------------------

- Issued 9,881,113 shares of common stock and Series C/D warrants to purchase up to 9,881,113 shares each at $0.3039 per share.
- Gross proceeds of $3M from offering, with potential additional $6M if warrants fully exercised on cash basis.
- Closing expected on October 31, 2024; H.C. Wainwright acted as exclusive placement agent with 6% cash fee.
- Net proceeds to be used for working capital, R&D, repayment or redemption of existing indebtedness, and capex.
- Warrants exercisable only after stockholder approval; Series C expires in 5 years, Series D in 18 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124044715/0001140361-24-044715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124044715/ny20037830x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-044715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer